For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
DelveInsight's Peridontal Disease - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Peridontal Disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Peridontal Disease from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Geography Covered
- The United States
- EU5 (Germany, France, Italy, Spain and the United Kingdom)
- Japan
Study Period: 2016-2027
Peridontal Disease - Disease Understanding and Treatment Algorithm
According to The American Academy of Periodontology, "Periodontal Diseases are bacterial gum infections that destroy the gums and supporting bone that hold our teeth in our mouth. Periodontal diseases can affect one tooth or many teeth. The main cause of periodontal diseases is bacterial plaque which is a sticky, colorless film that constantly forms on the teeth. If the plaque is not removed, it can turn into a hard substance called calculus or tartar in less than two days.
The DelveInsight Peridontal Disease market report gives the thorough understanding of the Peridontal Disease by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Peridontal Disease in the US, Europe, and Japan.
Peridontal Disease Epidemiology
The Peridontal Disease epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented as Prevalent Cases, Gender Specific Prevalence, and Diagnosed and Treatable Population] scenario of Peridontal Disease in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
As per DMS IV study it was found that in 2005, less than one percent of 35- to 44-year-olds had completely inflammatory and damage-free gums (women 0.5%, men 0.6%). This corresponds to a Community Periodontal Index (CPI) grade 0. Moderate periodontitis (CPI grade 3) was diagnosed in 2005 in 48.2% of women and 57.2% of men.
Peridontal Disease Drug Chapters
This segment of the Peridontal Disease report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
On the basis of treatment, the global periodontal therapeutics market can be segmented in terms of systemic antibiotics and local antibiotics. Systemic antibiotics include doxycycline, minocycline, metronidazole and local antibiotics include arestin, chlorhexidine etc. Some of the currently marketed drugs for Periodontal Disease include Periostat (CollaGenex Pharmaceuticals) and Trafermin (Kaken Pharmaceuticals).
Peridontal Disease Market Outlook
The Peridontal Disease market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
Key players such as Dexcel Pharma Technologies, Yuhan Corporation and many other are involved in developing therapies for Periodontal Disease. Expected launch of emerging therapies such as Perio Chip (Dexcel Pharma Technologies), YH23537 (Yuhan Corporation) and other therapies will significantly impact the Periodontal Disease market during the study period (2016-2027).
Peridontal Disease Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Peridontal Disease Report Insights
- Patient Population
- Therapeutic Approaches
- Pipeline Analysis
- Market Size and Trends
- Market Opportunities
- Impact of upcoming Therapies
Peridontal Disease Report Key Strengths
- 10 Years Forecast
- 7MM Coverage
- Epidemiology Segmentation
- Sub-type Segmentation
- Key Cross Competition
- Highly Analyzed Market
- Drugs Uptake
Peridontal Disease Report Assessment
- Current Treatment Practices
- Unmet Needs
- Pipeline Product Profiles
- Market Attractiveness
- Market Drivers and Barriers
Key Benefits
- This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving Peridontal Disease market
- Organize sales and marketing efforts by identifying the best opportunities for Peridontal Disease market
- To understand the future market competition in the Peridontal Disease market.